Product information

From Health Canada

No match found

No other product was found with the same active ingredient group.

The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.

Current status:

Marketed

Current status date:

2021-07-13

Original market date: See footnote 1

2016-07-20

Product name:

SODIUM NITRITE INJECTION, USP

Description:

10ML SINGLE USE VIAL

Help on accessing alternative formats, such as Portable Document Format (PDF), Microsoft Word and PowerPoint (PPT) files, can be obtained in the alternate format help section.

DIN:

02440466

Product Monograph/Veterinary Labelling:

Date: 2015-04-27 Product monograph/Veterinary Labelling (PDF version ~ 175K)

Company:

HOPE PHARMACEUTICALS LTD
170 422 Richards Street
Vancouver
British Columbia
Canada V6B 2Z4

Class:

Human

Dosage form(s):

Solution

Route(s) of administration:

Intravenous

Number of active ingredient(s):

1

Schedule(s):

Prescription

 

American Hospital Formulary Service (AHFS): See footnote 3

92:12.00 

Anatomical Therapeutic Chemical (ATC): See footnote 4

V03AB08 SODIUM NITRITE

Active ingredient group (AIG) number:See footnote5

0104384004

List of active ingredient(s)
Active ingredient(s) See footnote8 Strength
SODIUM NITRITE 30 MG / ML
Version 4.0.3

"Page details"

Date modified: